Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nickel Catalyzed Isomerization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114213367A details a novel nickel-catalyzed route to gamma-butyrolactone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel low-temperature isomerization process for diphenyl phenylphosphonate. Reduces impurities, enhances yield, and offers cost-effective manufacturing for polymer additives.
Patent CN110790649A details a novel Ni-catalyzed isomerization method for producing high-purity pharmaceutical intermediates with improved cost efficiency and supply chain stability.